UPDATED Mar 26, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RDOR3 | R$25.79 | -4.2% | 26.3% | R$60.0b | R$34.40 | PE33.8x | E28.4% | 1.4% | Healthcare | ||
HAPV3 | R$3.79 | -4.5% | 37.3% | R$28.9b | R$5.72 | PS1.1x | E86.3% | n/a | Healthcare | ||
HYPE3 | R$33.33 | -4.2% | -18.0% | R$21.6b | R$42.62 | PE12.8x | E14.9% | 3.7% | Pharmaceuticals & Biotech | ||
FLRY3 | R$14.98 | -1.3% | 8.3% | R$8.2b | R$19.90 | PE19.3x | E24.1% | 3.9% | Healthcare | ||
ODPV3 | R$11.57 | -8.9% | 3.6% | R$6.6b | R$12.80 | PE12.5x | E2.9% | 7.8% | Healthcare | ||
DASA3 | R$7.15 | -4.8% | -4.9% | R$5.4b | R$11.00 | PB0.7x | E99.6% | 0% | Healthcare | ||
ONCO3 | R$9.77 | -4.2% | 24.3% | R$5.0b | R$16.67 | PE22.6x | E36.6% | n/a | Healthcare | ||
MATD3 | R$6.00 | -8.4% | -21.8% | R$2.3b | R$9.98 | PE21.3x | E30.9% | 1.1% | Healthcare | ||
BLAU3 | R$12.15 | -2.2% | -50.9% | R$2.1b | R$15.57 | PE8.6x | E10.9% | 6.2% | Pharmaceuticals & Biotech | ||
VVEO3 | R$5.95 | -21.7% | -61.2% | R$2.1b | R$16.73 | PE5.3x | E15.4% | 4.7% | Healthcare | ||
OFSA3 | R$25.46 | 4.3% | 5.2% | R$1.3b | R$23.50 | PS1.5x | E55.3% | 2.2% | Pharmaceuticals & Biotech | ||
BIOM3 | R$9.08 | -5.6% | 132.2% | R$1.1b | n/a | PS9.3x | n/a | n/a | Pharmaceuticals & Biotech | ||
AALR3 | R$8.95 | 26.1% | -60.5% | R$1.0b | n/a | PB1.2x | n/a | 0% | Healthcare | ||
KRSA3 | R$0.87 | 0% | -5.4% | R$653.2m | R$1.55 | PB0.7x | E87.9% | n/a | Healthcare | ||
PFRM3 | R$5.46 | -0.7% | 75.6% | R$651.1m | n/a | PE9.5x | n/a | 2.1% | Healthcare | ||
QUAL3 | R$2.05 | -18.3% | -45.8% | R$597.6m | R$3.77 | PB0.5x | E84.7% | 3.9% | Healthcare |